Actively Recruiting
Droperidol and QTc Interval Changes in ED Patients
Led by CHRISTUS Health · Updated on 2024-12-17
500
Participants Needed
1
Research Sites
101 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Objectives To assess the association of low-dose Droperidol administration in the emergency department with changes in the QTc interval. Hypothesis Our study is designed to test the null hypothesis that there will be no clinically significant change in QTc interval after administration of 2.5mg of IV Droperidol during an emergency department visit.
CONDITIONS
Official Title
Droperidol and QTc Interval Changes in ED Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Emergency department patients aged 18 years or older
- Patients in a cardiovascular-monitored bed in the emergency department
- Patients who have an ECG and a 2.5 mg dose of intravenous Droperidol ordered by their treating physician
You will not qualify if you...
- Refusal to provide consent
- Receipt of Droperidol before the first ECG is performed
- Inability to complete consent and questionnaire due to clinical instability, severe pain, or disorientation as determined by a study physician
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
CHRISTUS Spohn Hospital Corpus Christi-Shoreline
Corpus Christi, Texas, United States, 78405
Actively Recruiting
Research Team
A
Aaron K Bartoe, DO, MS
CONTACT
P
Peter Richman, MD, MBA
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here